CELU
Celularity Inc
1.40$
+2.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 107 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | 290 | 291 | 521 | 293 | 292 | 451 | 431 | 405 | 388 | 448 | 414 | 434 | 429 | 437 | 401 | 362 | 246 | 157 | 157 | 144 | 144 | 129 | 133 | 133 | 120 | 114 | 107 | 107 | |
| 0.0 | 1.3 | 1.3 | 37 | 28 | 0.8 | 95 | 72 | 43 | 25 | 91 | 59 | 76 | 75 | 63 | 34 | 25 | 18 | 16 | 16 | 23 | 20 | 15 | 21 | 21 | 17 | 11 | 12 | 12 | |
| 0.0 | 1.2 | 1.0 | 28 | -28 | 0.7 | 81 | 54 | 23 | 8.2 | 73 | 37 | 48 | 38 | 43 | 14 | 8.5 | 3.1 | 0.3 | 0.3 | 1.9 | 0.2 | 0.1 | 0.7 | 0.7 | 0.9 | 0.1 | 6.2 | 6.2 | |
| 0.0 | 1.2 | 1.0 | 28 | 28 | 0.7 | 81 | 54 | 23 | 8.2 | 73 | 37 | 48 | 38 | 43 | 14 | 8.5 | 3.1 | – | 0.3 | – | 0.2 | 0.1 | – | 0.7 | 0.9 | 0.1 | – | 6.2 | |
| – | – | – | 3.1 | – | – | -0.8 | 6.6 | 6.5 | 0.9 | 3.7 | 5.2 | 6.0 | 3.9 | 8.4 | 7.0 | 5.2 | 4.9 | 4.1 | 6.2 | 14 | 12 | 8.8 | 14 | 14 | 11 | 6.7 | 4.7 | 4.7 | |
| – | – | – | 3.2 | – | – | 1.6 | 3.9 | 5.0 | 4.5 | 5.7 | 9.5 | 15 | 25 | 5.2 | 5.3 | 5.5 | 5.7 | 4.9 | 4.9 | 3.7 | 5.8 | 4.0 | 5.4 | 5.4 | 4.4 | 2.6 | 0.6 | 0.6 | |
| – | – | – | – | – | – | – | 90 | 90 | 90 | 95 | 91 | 81 | 80 | 101 | – | 99 | 86 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 127 | – | – | 123 | 123 | 123 | 123 | 123 | 123 | 123 | 123 | 123 | 120 | 90 | 90 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | |
| – | – | – | 271 | – | – | 126 | 125 | 125 | 124 | 124 | 123 | 123 | 122 | 122 | 121 | 120 | 12 | 12 | 12 | 10 | 11 | 9.6 | 9.2 | 9.2 | 8.5 | 8.1 | 7.8 | 7.8 | |
| 0.2 | 11 | 11 | 384 | 11 | 11 | 437 | 412 | 467 | 486 | 352 | 315 | 344 | 279 | 273 | 202 | 207 | 128 | 127 | 127 | 113 | 103 | 112 | 124 | 124 | 146 | 134 | 145 | 145 | |
| 0.2 | 0.2 | 0.1 | 21 | 0.1 | 0.2 | 26 | 27 | 25 | 33 | 29 | 26 | 26 | 33 | 69 | 62 | 66 | 65 | 85 | 85 | 66 | 67 | 76 | 54 | 54 | 69 | 65 | 81 | 81 | |
| – | – | – | – | – | – | – | 3.0 | 3.0 | 8.0 | 3.0 | 3.1 | – | – | 39 | 38 | 31 | 17 | – | 35 | – | 39 | 43 | – | 6.4 | 6.9 | 5.7 | – | 14 | |
| – | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 8.7 | 5.4 | 5.5 | 6.7 | 7.0 | 9.3 | 10 | 10 | 9.2 | 5.8 | 8.8 | 12 | 13 | 13 | 13 | 14 | 15 | 23 | 23 | 24 | 25 | 26 | 26 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.7 | 17 | – | – | – | – | – | 36 | 36 | 36 | – | – | – | |
| 0.0 | 279 | 280 | 138 | 138 | 281 | 13 | 19 | -62 | -98 | 96 | 99 | 90 | 150 | 164 | 199 | 156 | 119 | 30 | 30 | 31 | 41 | 17 | 8.8 | 8.8 | -25 | -20 | -38 | -38 | |
| 0.0 | 0.6 | 1.8 | -355 | 3.5 | 3.4 | -567 | -564 | -645 | -710 | -660 | -664 | -723 | -675 | -670 | -645 | -710 | -757 | -851 | -851 | -864 | -842 | -886 | -900 | -900 | -944 | -967 | -991 | -991 | |
| 3.6 | 3.5 | 3.6 | 2.4 | 2.4 | 2.4 | 1.8 | 1.8 | 2.4 | 2.4 | 12 | 12 | 13 | 15 | 15 | 15 | 16 | 18 | 19 | 19 | 22 | 19 | 22 | 23 | 22 | 24 | 26 | 29 | 26 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.